Article

PTCE Announces New ‘Faces of Pharmacy’ Winners in Recognition of American Pharmacists Month

This yearlong campaign recognizes pharmacists for their dedication, and often overlooked contributions, to transforming health care.

In support of American Pharmacists Month in October, PTCE, a leader in continuing education for multispecialty pharmacists and pharmacy professionals, is committed to recognizing pharmacists’ contributions to health care practices and all they do for their communities through its ‘Faces of Pharmacy’ recognition program.

In this transforming health care landscape, The Faces of Pharmacy nomination opportunity celebrates pharmacists, who navigate evolving health care practices and continue to make a difference in the lives of their patients.

Continuing its year-long campaign, PTCE is proud to announce its September winners:

  • Alisa Eibling, PharmD, clinical director, PFSP Specialty Pharmacy
  • Adam King, MPH, CPhT, PR, executive director and founder, CompassionRx
  • Jameika Stuckey, PharmD, clinical supervisor and medication safety manager, University of Mississippi Medical Center
  • Michael Lorenzo Tinglin, PharmD, clinical pharmacist, Premier Family Medical

“Congratulations to the 4 pharmacy professionals who were selected as the winners of our Faces of Pharmacy program,” said Jim Palatine, RPh, MBA, president of PTCE, in a prepared statement. “The number of nominations we have received for the month of September truly exemplifies the need and desire to acknowledge these health care professionals who make a difference in the lives of their patients. In honor of American Pharmacists Month, we are devoted to showing our appreciation for the care and commitment of pharmacy professionals in the industry, and we will continue to recognize these professionals every month with our inaugural yearlong campaign.”

Each month, PTCE will select 4 pharmacy professionals to feature on its website and social media platforms in recognition of their unwavering commitment to delivering exceptional care to patients.

Nominations can be submitted online by colleagues, patients, friends and family members of outstanding pharmacists, pharmacy technicians or anyone else working in the industry. Submissions should detail what the nominee has done to ensure access to treatment and care or describe how they go above and beyond to support their patients or community.

Visit PTCE’s website to learn more about each of the 4 new winners.

REFERENCE

PTCE Announces September ‘Faces of Pharmacy’ Winners in Recognition of American Pharmacists Month [news release]. Cranbury, NJ; October 8, 2020: Pharmacy Times Continuing EducationTM. Accessed October 8, 2020. https://www.businesswire.com/news/home/20201008005978/en/PTCE-Announces-September-%E2%80%98Faces-of-Pharmacy%E2%80%99-Winners-in-Recognition-of-American-Pharmacists-Month

Related Videos
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Hurricane Helene, Baxter plant, IV fluids shortage, health systems impact, injectable medicines, compounding solutions, patient care errors, clinical resources, operational consideration, fluid conservation, sterile water, temperature excursions, training considerations, patient safety, feedback request
Image Credit: © peopleimages.com - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards